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Abstract 
The adduct O6-carboxymethyl-2’-deoxyguanosine (O6CMdG) is of importance as it has been 
previously linked to a high red meat diet in humans and, as yet, a LC-MS method has not 
been developed due to lack of appropriate standards. The synthesis of the deuterated and C-
13 analogues required the use of [2H2]- and [13C2]ethyl glycolate to label the carboxymethyl 
moiety of O6CMdG. [2H2]Ethyl glycolate was synthesised via acid hydrolysis of ethyl 
diazoacetate using deuterated solvents (59% yield), whilst [13C2]ethyl glycolate was 
synthesised from [13C2]glycine in a three step procedure (35% yield). The labelled ethyl 
glycolates were then used to synthesise [2H2]- and [13C2]O6CMdG for future use as internal 
standards in the LC-MS analysis of biological samples. 
Keywords stable labelled synthesis, C-13, H-2, O6-carboxymethyl-2’-deoxyguanosine, 
O6CMdG, ethyl glycolate, LC-MS 
Introduction 
Cancer is a disease that afflicts approximately one-third of the global population at some 
point in their lifetimes. Consequently, there is a vast quantity of research into the mechanisms 
and prevention of cancer, and differences have been found according to geographical regions 
which has been linked to a numbers of factors including diet[1]. Mutagenic and carcinogenic 
compounds arise from many exogenous and endogenous routes, including diet, and may 
result in chemical modifications to the DNA structure, i.e. DNA adducts. One such adduct is 
O6-carboxymethyl- 2’-deoxyguanosine (O6CMdG) that has been linked to nitrosated amines 
from red meat diets[2]. Previous research has examined this adduct using an immunoslot blot 
assay which is very sensitive but only a single adduct can be analysed at a time and 
difficulties can occur due to cross-reactivity of the antibodies[3, 4]. A limited supply of a 
polyclonal antibody does exist for O6CMdG but attempts to produce a monoclonal antibody 
have been unsuccessful and a different technique will therefore be needed in the future. There 
has been considerable progress in the area of DNA adduct analysis by LC-MS and good 
sensitivity can be achieved(e.g.[5]). Hence, we pursued the use of LC-MS as a more selective, 
and potentially sensitive, technique to analyse DNA adducts in biological samples. The 
synthesis of unlabelled O6CMdG, 1 (Scheme 1),  has been reported by other researchers[6] 
where methyl glycolate was used to furnish the carboxymethyl group at the O6 position of 2’-
deoxyguanosine. However, we utilized ethyl glycolate due to the availability of starting 
materials to insert the labelled atoms for [2H2]- and [13C2]O6CMdG, 2 and 3.  Hence this 
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research initially focussed on the synthesis of [2H2]- and [13C2]ethyl glycolate (4 and 5 
(Scheme 2)) and subsequently that of 2 and 3.  
[Insert Scheme 1] 
[Insert Scheme 2] 
Experimental 
General 
All chemicals were purchased from Sigma-Aldrich (Dorset, UK) and used without further 
purification. Solvents were purchased from Fisher (Loughborough, UK). Organic extracts 
were dried over MgSO4. NMR data where obtained on Bruker Avance 300 
spectrometer at 300.1 MHz (1H) or 75.5 MHz (13C). Chemical shifts were determined relative 
to the residual solvent peak and reported as parts per million (ppm) and coupling constants in 
Hz.  Reactions and purifications were monitored by HPLC on a Waters Alliance system 
equipped with a Waters 996 photodiode array detector with a narrow-bore Hypersil BDS C18 
column (3 µm, 100 × 2.1 mm), flow rate 0.2 ml/min, MeOH/0.02 M ammonium acetate (pH 
5.4) 80:20. ESI-MS spectra were recorded on VG Quattro mass spectrometer with a narrow-
bore Hypersil BDS C18 column (3 µm, 100 × 2.1 mm), flow rate 0.2 ml/min and 0.1% 
formic acid/methanol gradient. 
Glycine ethyl ester hydrochloride 
Glycine (0.5 g, 6.66 mmol) was suspended in ethanol (15 cm3) and acetyl chloride (1.5 cm3, 
21.12
 
mmol), and heated at 85° C for 30 mins under N2. The solvents were removed to give a 
white powder (1.01 g, >100% yield). NMR (D2O) δH ppm 1.19 (3H, t, CH3, J = 7.14), 3.81 
(2H, s, N-CH2), 4.20 (2H, q, O-CH2, J = 7.14); δC ppm 14.03 (CH3), 41.05 (N-C), 64.16 (O-
CH2), 169.00 (C=O) 
[13C2]Glycine ethyl ester hydrochloride 
[13C2]Glycine (0.5 g, 6.49 mmol) was reacted as above to give a white powder (0.93 g, 
>100% yield). NMR (D2O) δH ppm 1.17 (3H, t, CH3, J = 7.14), 3.79 (2H, dd, N-CH2, JCH = 
145.64, 6.32), 4.19 (2H, dq, O-CH2, JHH = 7.14, JCH 2.94); δC ppm 14.02 (CH3), 41.02 (N-C, 
d, J = 62.40), 64.15 (O-CH2), 169.00 (C=O, d, J = 62.40) 
Ethyl diazoacetate 
Glycine ethyl ester.HCl (0.99 g, 7.09 mmol) was dissolved in water (1.8 cm3) and 
dichloromethane (4 cm3), stirred and cooled to -10° C. Aq. sodium nitrite (4.43 M, 1.8 cm3) 
was added to the cooled solution, then 5% H2SO4 (0.65 cm3) was added dropwise and the 
solution stirred for 10 mins. The organic layer was poured into 5% NaCO3 at 0° C. The 
aqueous layer was extracted with dichloromethane and the organic extract combined with the 
organic/NaCO3 solutions. The combined solution was shaken thoroughly and the pH checked 
to ensure that it was alkaline. The solvents were removed to give 0.66 g of a pale yellow oil 
(5.78 mmol, 82% yield). NMR (CDCl3) δH ppm 1.21 (3H, t, CH3, J = 7.14 Hz), 4.15 (2H, q, 
CH2, J = 7.14), 4.67 (1H, CH); δC ppm 14.43 (CH3), 46.11 (CH), 60.84 (CH2), 166.86 (C=O) 
[13C2]Ethyl diazoacetate 
[13C2]Glycine ethyl ester.HCl (0.80 g, 5.65 mmol) was reacted as described above to give a 
pale yellow oil (0.36 g, 55% yield). NMR (CDCl3) δH ppm 1.21 (3H, t, CH3, J = 7.14), 4.15 
(2H, dq, CH2, JHH = 7.14, JCH = 3.30), 4.75 (1H, d, CH, JCH = 259.05); δC ppm 14.41 (CH3), 
46.12 (CH, d, J = 96.84), 60.85 (CH2), 166.87 (C=O, d, J = 96.84) 
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Ethyl diazoacetate (0.40 g, 3.51 mmol) was dissolved in dichloromethane (6 cm3) and 1% 
aqueous acetic acid (6 cm3) added and stirred for 72 h in the dark. The aqueous layer was 
extracted with dichloromethane, and the organic extracts combined with the organic layer, 
washed with water, dried and the solvents removed to give a pale yellow oil (0.24 g, 66% 
yield). NMR (CDCl3) δH ppm 1.23 (3H, t, CH3, J = 7.14 Hz), 4.08 (2H, s, CH2OH), 4.20 (2H, 
q, CH2CH3, J = 7.14); δC ppm 14.21 (CH3), 53.32 (CH2CH3), 61.64 (CH2OH), 173.42 (C=O) 
[2H2]Ethyl glycolate (4) 
Ethyl diazoacetate (10 cm3, 96.41 mmol) was reacted as above substituting D2O for H2O, and 
d-acetic acid for acetic acid to give a pale yellow oil (6.05 g, 59% yield). NMR (CDCl3) δH 
ppm 1.28 (3H, t, CH3, J = 5.36), 4.24 (2H, q, CH2, J = 5.36)   
[13C2]Ethyl glycolate (5) 
[13C2]Ethyl diazoacetate (0.40 g, 3.49 mmol) was reacted as for ethyl glycolate to give a pale 
yellow oil (0.24 g, 66% yield). NMR (CDCl3) δH ppm 1.26 (3H, t, CH3, J = 7.14), 4.08 (2H, 
dd, CH2OH, JCH = 145.56, 5.13), 4.15 (2H, dq, JHH = 7.14, JCH = 3.30); δC ppm 14.13 (CH3), 
53.40 (CH2CH3), 60.53 (CH2OH, d, J = 58.93), 173.32 (C=O, d, J = 58.93) 
O6-[1-azonia-bicyclo[2.2.2]octane]-3’,5’-bis-O-(isobutyryloxy)-2’-deoxyguanosine  
Step (i): 2’-deoxyguanosine (1.05g, 3.74 mmol) was dried twice from toluene (20 cm3) and 
dissolved in dry tetrohydrofuran (20 cm3) with 4-(dimethylamino)pyridine (DMAP) (0.024 g, 
0.2 mmol) and iso-butyric anhydride (2 cm3, 12.13 mmol) and stirred under N2 for 16 h. 
NaHCO3 (aq) was added to give pH 8 and stirred for 2 h. The solvent was removed and the 
precipitate collected, washed (H2O) and dried to give a white powder (1.30 g, 85% yield). 
Step (ii): The product of (i) (1.00 g, 2.45 mmol) was dissolved in dry dichloromethane (30 
cm3) with DMAP (0.03 g, 0.25 mmol) and methanesulfonyl chloride (1.00 g, 8.73 mmol), 
triethylamine (3 cm3) was added dropwise and stirred for 3 h. Purification was carried out on 
silica (chloroform/methanol, 97:3) to give a yellow oil (1.86 g, 98% yield). Step (iii): The 
product of (ii) was dissolved in dry dichloromethan  (30 cm3) with quinuclidine HCl (1.0 g, 
6.77 mmol) and dry triethylamine (3 cm3) and stirred for 2 h. TLC showed a single blue spot 
on the baseline (methanol/dichloromethane, 10:90). The solvent was removed and the 
product used in further reactions without purification.  
O6-Carboxymethyl-2’-deoxyguanosine. Na (1) 
Step (iv): The product from (iii) was dissolved in dry dichloromethane (20 cm3).  Methyl 
glycolate (0.5 cm3, 6.48 mmol) and 1,8-Diazabicyclo[5.4.0]undec-7-ene (0.5 cm3, 3.35 mmol) 
were added and stirred for 16 h. The solvents were removed and the resulting oil purified on 
silica (methanol/dichloromethane, 5:95) to give a yellow oil (1.60 g). Step (v):  the oil was 
dissolved in methanol (20cm3) with triethylamine (1 cm3) and stirred for 72 h. The solvents 
were removed to give a yellow oil (1.67 g) which was purified on a Supelclean Envi-18 6 ml 
column (Supelco, USA) pre-conditioned with methanol (2 cm3), then H2O (2 cm3). The 
sample was applied to the column in H2O (0.5 cm3), eluted, washed with H2O (2 cm3), then 
5% methanol / 95% H2O (2 cm3). The pure fractions were lyophilised to give a slightly 
yellow powder (0.075 g). Step (vi): the powder was dissolved in 0.1 M NaOH (4.4 cm3) and 
stirred for 4 h, then lyophilised to give 1 as a white powder (0.080 g, 6.2% overall yield). 
NMR (DMSO) δH 2.21 (1H, m, 2’-H), 2.59 (1H, m, 2’-H), 3.53 (2H, m, 5’-H), 3.83 (1H, m, 
4’-H), 4.37 (1H, m, 3’-H), 4.58 (2H, s, CH2), 5.17 (1H, br, 5’-OH), 5.44 (1H, br, 3’-OH), 
6.19 (1H, t, 1’-H, J = 6.27), 6.22 (2H, s, NH2), 8.06 (1H, s, 8-H); δC ppm 39.49 (2’-C), 61.64 
(5’-C), 64.86 (CH2), 70.69 (3’-C), 82.70 (1’-C), 87.57 (4’-C), 114.37 (5-C), 137.23 (8-C), 
153.45 (6-C), 159.60 (2-C), 160.74 (4-C), 170.40 (COOH); M- 324 
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Steps (iv-vi) were performed as for 1 substituting 4 (1 cm3, 10.37 mmol) for methyl glycolate, 
and D2O for H2O to give 2 as a white powder (83.4 mg, 6.4% overall yield). NMR (DMSO) 
δH ppm 2.27 (1H, m, 2’-H), 2.65 (1H, m, 2’-H), 3.60 (2H, m, 5’-H), 3.89 (1H, m, 4’-H), 4.43 
(1H, m, 3’-H), 5.19 (1H, br, 5’-OH), 5.45 (1H, br, 3’-OH), 6.27 (1H, t, 1’-H, J = 6.87), 6.34 
(2H, s, NH2), 8.14 (1H, s, 8-H);  δC  ppm 35.42 (2’-C), 61.99 (5’-C), 68.41 (CD2), 70.85 (3’-
C), 83.40 (1’-C), 87.82 (4’-C), 114.39 (5-C), 133.95 (8-C), 140.22 (6-C), 143.54 (2-C), 
160.15 (4-C), 175.65 (COOH); M- 326 
[13C2]O6-Carboxymethyl-2’-deoxyguanosine.Na (3) 
Steps (iv-vi) were performed as for 1 substituting 5 (0.2 cm3, 2.07 mmol) for methyl 
glycolate to give 3 as a white powder (3.5 mg, 0.52% overall yield). NMR (DMSO) δH ppm 
2.59 (2H, m, 2’-H), 3.57 (2H, m, 5’-H), 3.83 (1H, m, 4’-H), 4.37 (1H, m, 3’-H), 4.53 (1H, dd, 
CH2, J = 3.83, 145.49), 5.07 (1H, br, 5’-OH), 5.30 (1H, br, 3’-OH), 6.18 (1H, t, 1’-H, J = 
6.86), 6.30 (2H, s, NH2), 8.04 (1H, s, 8-H);  δC ppm 36.90 (2’-C), 61.76 (5’-C), 64.98 (CH2, J 
= 54.19), 70.76 (3’-C), 82.75 (1’-C), 87.55 (4’-C), 114.43 (5-C), 137.07 (8-C), 153.42 (6-C), 
159.57 (2-C), 160.95 (4-C), 169.39 (COOH, J = 54.19); M- 326 
Results and discussion 
The synthesis of 1 was carried out with methyl glycolate and gave a lower overall yield 
(6.2%) than previously reported[6] despite several attempts to improve yields at each stage. 
We then investigated the hydrolysis of ethyl diazoacetate to give ethyl glycolate in both 
aqueous and deuterated solvents (Scheme 2, step (iii)). As discussed later, the C-13 labelled 
ethyl glycolate was subsequently required; hence the procedure was extended to give ethyl 
glycolate from glycine (Scheme 2). Kresge and Popik had shown that the hydrolysis of 
diazoketones took place in both water and deuterium oxide to give the corresponding 
alcohol[7]. Whilst they found that the reactions took place at different rates according to the 
structure of the diazoketone, single products were acquired in high yield. We found that the 
hydrolysis of ethyl diazoacetate proceeded well under both conditions and with no substantial 
difference in the yields. The NMR for the unlabelled compound showed a singlet for the 
CH2-OH protons at 4.1 ppm that was not present in 4 confirming that the diazo group was 
converted to the alcohol with 100% incorporation of deuterium at the α-carbon. Subsequently 
4 was used to give 2 (Scheme 1) in a low overall yield (6.4%) which was comparable with 1. 
Deuterium-proton exchange was evident in 2 as the NMR revealed protons at the CH2 
position (17%) of the carboxymethyl group which had not been present in 4. This was 
improved by performing the final step in D2O (11%) but it is not known whether the 
exchange occurred during the synthesis or purification of 2. However, the NMR spectra of 
intermediates suggest that some exchange was occurring at each stage. Furthermore, the use 
of the 2 in LC-MS revealed additional deuterium-proton exchange resulting in peaks in the 
mass spectrum corresponding to single and di-deuterated compounds. Hence, a C-13 labelled 
O6CMdG standard (3) was required for use as a stable LC-MS standard. 
[13C2]Glycine was converted to the ethyl ester by reaction with acyl chloride rather than an 
acid/ethanol reflux which had given lower yields in initial attempts (data not shown). The 
conversion to [13C2]ethyl diazoaceate was performed by a known procedure[8], and converted 
to 5 in the same manner as for 4. The major difference in the NMR, between the labelled and 
unlabelled compounds, was either the lack of a peak or the very large coupling constants 
observed between protons and the C-13 atoms in the labelled compounds which enabled 
unambiguous assignment of the NMR spectra. The C-13 labelled compounds had peaks for 
the α-H that showed splitting due to coupling to the two C-13 atoms with the exception of 
[13C2]ethyl diazoacetate. This compound had broader peaks than the other compounds, 
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possibly due to the diazo group charge distribution, which did not allow observation of the 
splitting due to coupling with the carbonyl C-13 as well as the α-C. The synthesis of 3 was 
then performed in the same manner as for 2, and the double splitting pattern of the α-H was 
observed. However, for 3, the limiting factor was the quantity of 5 that was available due to 
the high cost of the material. Hence, yields for intermediates of Scheme 1 (steps (iv-vi)) of 3 
were expected to be much lower and the purification was more difficult due to the high 
quantity of unreacted precursors. Nevertheless, sufficient pure material was obtained (0.52% 
yield) for use as an internal standard and the problem of deuterium-proton exchange had been 
overcome.  
Conclusion 
Both of the labelled ethyl glycolates, 4 and 5, were obtained in high yield. However, when 4 
was used to synthesise 2, some deuterium-proton exchange was observed. This was 
exacerbated when LC-MS analysis was attempted. The synthesis of 5 did not pose any major 
problems but this compound then became the limiting factor in the synthesis of 3. In terms of 
cost, 2 was the preferred option but proved to be problematic for LC-MS analysis. Thus, 5, 
the C-13 labelled analogue of O6CMdG was obtained in sufficient yield for future analyses of 
biological samples by LC-MS. 
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Scheme 1 Synthesis of O6CMdG (1), [2H2]O6CMdG (2) and [13C2]O6CMdG (3) 
 
Scheme 2 Synthesis of [2H2]- and [13C2]ethyl glycolate (4 and 5) 
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Scheme 1 Synthesis of O6CMdG (1), [2H2]O
6CMdG (2) and [13C2]O
6CMdG (3)  
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Scheme 2 Synthesis of [2H2]- and [
13C2]ethyl glycolate (4 and 5)  
167x36mm (300 x 300 DPI)  
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